Cargando…

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer

Recent studies have reported that TUBB3 overexpression is involved in docetaxel (DTX) resistance in prostate cancer (PCa). The aim of this study was to clarify the role of TUBB3 in DTX and cabazitaxel (CBZ) resistance, and cross-resistance between DTX and CBZ in PCa. We analyzed the effect of TUBB3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekino, Yohei, Han, Xiangrui, Kawaguchi, Takafumi, Babasaki, Takashi, Goto, Keisuke, Inoue, Shogo, Hayashi, Tetsutaro, Teishima, Jun, Shiota, Masaki, Yasui, Wataru, Matsubara, Akio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719236/ https://www.ncbi.nlm.nih.gov/pubmed/31412591 http://dx.doi.org/10.3390/ijms20163936

Ejemplares similares

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)

HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019)

Claspin overexpression is associated with high‐grade histology and poor prognosis in renal cell carcinoma
por: Kobayashi, Go, et al.
Publicado: (2020)

Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer
por: Sekino, Yohei, et al.
Publicado: (2017)

Fibroblast Growth Factor Family in the Progression of Prostate Cancer
por: Teishima, Jun, et al.
Publicado: (2019)

Combination therapy using molecular‐targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma
por: Kitano, Hiroyuki, et al.
Publicado: (2017)

Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted laparoscopic prostatectomy
por: Inoue, Shogo, et al.
Publicado: (2020)

Change of preoperative symptoms of the late-onset hypogonadism syndrome after robot-assisted radical prostatectomy
por: Teishima, Jun, et al.
Publicado: (2021)

Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment
por: Goto, Keisuke, et al.
Publicado: (2021)

Molecular mechanisms of docetaxel resistance in prostate cancer
por: Sekino, Yohei, et al.
Publicado: (2020)

Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade
por: Hatayama, Tomoya, et al.
Publicado: (2019)

Pneumatosis cystoides intestinalis linked to sunitinib treatment for renal cell carcinoma
por: Shikuma, Hiroyuki, et al.
Publicado: (2019)

Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma
por: Kobatake, Kohei, et al.
Publicado: (2022)

Evaluation of urinary catheters for effective manual bladder washout
por: Kobatake, Kohei, et al.
Publicado: (2022)

AB171. Regeneration of rat corpus cavernosa tissue after transplantation of human bone-marrow-derived CD133(+) cells
por: Inoue, Shogo, et al.
Publicado: (2015)

Refractory fistula of bladder repaired with transurethral cystoscopic injection of N‐butyl‐2‐cyanoacrylate
por: Mukai, Sakurako, et al.
Publicado: (2019)

KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress‐related tumorigenicity
por: Takemoto, Kenshiro, et al.
Publicado: (2022)

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma
por: Teishima, Jun, et al.
Publicado: (2023)

Regeneration of rat corpora cavernosa tissue by transplantation of CD133(+) cells derived from human bone marrow and placement of biodegradable gel sponge sheet
por: Inoue, Shogo, et al.
Publicado: (2017)

Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma
por: Sekino, Yohei, et al.
Publicado: (2018)

Postoperative around-the-clock administration of intravenous acetaminophen for pain control following robot-assisted radical prostatectomy
por: Inoue, Shogo, et al.
Publicado: (2021)

Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer
por: James, Nicholas D., et al.
Publicado: (2022)

The secondary tumor of the prostate derived from upper tract urothelial carcinoma: An autopsy case
por: Goto, Keisuke, et al.
Publicado: (2021)

Anastomosing haemangioma with fatty changes in the perirenal space: a lesion mimicking liposarcoma
por: Kishida, Naotaka, et al.
Publicado: (2017)

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer
por: Calcagno, Fabien, et al.
Publicado: (2012)

Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy
por: Taniyama, Daiki, et al.
Publicado: (2021)

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy
por: TEISHIMA, JUN, et al.
Publicado: (2014)

Initial treatment outcome and feasibility of low-dose cabazitaxel against docetaxel- and castration-resistant prostate cancer in a Japanese hospital
por: Chaya, Ryosuke, et al.
Publicado: (2020)

Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate cancer patients with PTEN alterations
por: Kamisawa, Ken, et al.
Publicado: (2022)

STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
por: Rocha, Sandra M., et al.
Publicado: (2023)

Long-term efficacy of penile rehabilitation with low-intensity extracorporeal shock wave therapy for sexual and erectile function recovery following robotic-assisted radical prostatectomy: a single-cohort pilot study
por: Kohada, Yuki, et al.
Publicado: (2023)

TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer
por: Pham, Quoc Thang, et al.
Publicado: (2021)

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients
por: Terada, Naoki, et al.
Publicado: (2019)

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor
por: Teishima, Jun, et al.
Publicado: (2021)

MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma
por: Kobayashi, Go, et al.
Publicado: (2023)

Editorial Comment to Rare case of carcinoma in situ originated in right retrocaval ureter successfully managed with laparoscopic procedure
por: Sekino, Yohei, et al.
Publicado: (2020)

Editorial Comment to Knotted ureteral single‐J stent in a patient with ureterocutaneostomy
por: Sekino, Yohei, et al.
Publicado: (2021)

Editorial Comment to Rare case of immunoglobulin G4‐related disease arising in gonadal glands with long‐term remission without steroid treatment: Discussion and literature review
por: Sekino, Yohei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mj4a5ov26c47u3sjdf3ufsjiqu